Product Images Nalbuphine Hci

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 7 images provide visual information about the product associated with Nalbuphine Hci NDC 51662-1420 by Hf Acquisition Co Llc, Dba Healthfirst, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

CARTON LABELING - Box Labeling

CARTON LABELING - Box Labeling

This is a product description of a pharmaceutical compound known as EPVS Black s, contained in a multi-dose flip-top vial. Each milliliter (mL) of the solution comprises nalbuphine HC1, sodium citrate dihydrate, citric acid, anhydrous, methyparaben, and propyparaben with the addition of buffers, preservatives, and sodium chloride to adjust pH and osmolality. The recommended dose is not specified in the available text. The vial should be stored in a controlled room temperature range (20-25°C or 68-77°F) and protected from light until use. The text also includes instructions for handling and packaging the product.*

BOXED WARNING - Boxed Warning

BOXED WARNING - Boxed Warning

This text is a warning about the potential life-threatening risks of using Nalbuphine Hydrochloride Injection with benzodiazepines or other central nervous system depressants. The combination can lead to respiratory depression, sedation, coma, and death. Dosages and durations of use should be kept to a minimum, and patients should be closely monitored for signs of these adverse effects. Physicians should only prescribe Nalbuphine Hydrochloride Injection together with benzodiazepines or other CNS depressants as a last resort when alternative treatment options are inadequate.*

HOW SUPPLIED - How Supplied

HOW SUPPLIED - How Supplied

This is a description of the various packaging sizes and concentrations of a medication, which is available in ampuls and vials. The medication comes in concentrations of 10mg/mL, 20mg/mL, 100mg/10mL and 200mg/10mL, and is packaged in single-dose ampuls or multiple-dose fliptop vials. The NDC (National Drug Code) numbers provided indicate the codes used to identify the medication in the USA.*

LOGO - Logo

LOGO - Logo

SERIALIZED LABELING - Serialized Labeling

SERIALIZED LABELING - Serialized Labeling

STRUCTURE - Structure

STRUCTURE - Structure

VIAL LABELING - Vial Labeling

VIAL LABELING - Vial Labeling

This is a description for a medication called Nalbuphine HCI injection. It is a multiple-dose solution with a strength of 10mg/ml. The solution contains nalbuphine HCI, sodium citrate, citric acid, methylparaben, and propylparaben as preservatives. It can be used for IV, IM, or SC injections and should be stored at 20 to 25°C (68 to 77°F). The usual dosage can be found in the insert. This medication is sterile and should be protected from light.*

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.